Human P2Y(6) receptor: molecular modeling leads to the rational design of a novel agonist based on a unique conformational preference

J Med Chem. 2005 Dec 29;48(26):8108-11. doi: 10.1021/jm050911p.

Abstract

Combining molecular dynamics (MD) in a hydrated phospholipid (DOPC) bilayer, a Monte Carlo search, and synthesis of locked nucleotide analogues, we discovered that the Southern conformation of the ribose is preferred for ligand recognition by the P2Y(6) receptor. 2'-Deoxy-(S)-methanocarbaUDP was found to be a full agonist of the receptor and displayed a 10-fold higher potency than that for the corresponding flexible 2'-deoxyUDP. MD results also suggested a conformational change of the second extracellular loop consequent to agonist binding.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Humans
  • Ligands
  • Models, Molecular
  • Molecular Conformation
  • Purinergic P2 Receptor Agonists*
  • Receptors, Purinergic P2 / metabolism
  • Tumor Cells, Cultured
  • Uridine Diphosphate / analogs & derivatives*
  • Uridine Diphosphate / metabolism

Substances

  • Ligands
  • Purinergic P2 Receptor Agonists
  • Receptors, Purinergic P2
  • purinoceptor P2Y6
  • Uridine Diphosphate